Pharmacological characterization of M-II, the major human metabolite of ramelteon (Q48100506)

8 February 2018

title

Pharmacological characterization of M-II, the major human metabolite of ramelteon (English)

1 reference

8 February 2018

author name string

Keiji Nishiyama

1

1 reference

8 February 2018

Hisao Nishikawa

2

1 reference

8 February 2018

Koki Kato

3

1 reference

8 February 2018

Masaomi Miyamoto

4

1 reference

8 February 2018

Tetsuya Tsukamoto

5

1 reference

8 February 2018

Keisuke Hirai

6

1 reference

8 February 2018

publication date

6 June 2014

1 reference

8 February 2018

published in

Pharmacology

1 reference

8 February 2018

volume

93

1 reference

8 February 2018

issue

3-4

1 reference

8 February 2018

page(s)

197-201

1 reference

8 February 2018

The association between the nocturnal sleep gate and nocturnal onset of urinary 6-sulfatoxymelatonin.

cites work

1 reference

Sleep-inducing effects of low doses of melatonin ingested in the evening.

21 January 2018

1 reference

Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses

21 January 2018

1 reference

Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor

21 January 2018

1 reference

Melatonin induction of filamentous structures in non-neuronal cells that is dependent on expression of the human mt1 melatonin receptor.

21 January 2018

1 reference

International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors

21 January 2018

1 reference

Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist

21 January 2018

1 reference

An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia

21 January 2018

1 reference

Acute sleep-promoting action of the melatonin agonist, ramelteon, in the rat.

21 January 2018

1 reference

Meta-analysis: melatonin for the treatment of primary sleep disorders

21 January 2018

1 reference

Disposition kinetics and tolerance of escalating single doses of ramelteon, a high-affinity MT1 and MT2 melatonin receptor agonist indicated for treatment of insomnia

21 January 2018

1 reference

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

21 January 2018

1 reference

Sleep-wake characterization of double MT₁/MT₂ receptor knockout mice and comparison with MT₁ and MT₂ receptor knockout mice.

21 January 2018

1 reference

Promotion of non-rapid eye movement sleep and activation of reticular thalamic neurons by a novel MT2 melatonin receptor ligand

21 January 2018

1 reference

Sleep-promoting action of IIK7, a selective MT2 melatonin receptor agonist in the rat

21 January 2018

1 reference

Neurobiology, pathophysiology, and treatment of melatonin deficiency and dysfunction

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000362459

1 reference

8 February 2018

1 reference

8 February 2018